Acceptance of Telemedicine During the COVID-19 Pandemic

Covid-19 Clinical Trial

Official title:

Acceptance of Telemedicine in Outpatient Clinic Consultations During COVID-19 Pandemic. An International, Cross-sectional Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04400448
• Other study ID #: TELECOVID
• Status: Not yet recruiting
• Start date: June 1, 2020
• Est. completion date: October 31, 2020

Study information

• Verified date: May 2020
• Source: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Currently, due to the effects of COVID-19 pandemic, there is an imperative need to change the healthcare model. In this regard, telemedicine has proved very useful in health crises, in which there is a possibility of infection between people, offering remote access to medical care. Telemedicine has been used in many chronic diseases such as asthma and chronic obstructive pulmonary disease, diabetes mellitus, and appears to be well accepted by patients. However, few studies have been conducted in surgical services and in other diseases. Therefore, the aim of this study is to assess the level of acceptance of the patients, in this pandemic situation, to a telemedicine follow-up in different departments.

This is an observational, cross-sectional, multicenter and international study with prospective and retrospective data collection. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ). In addition, all patients will provide an overall satisfaction score for telemedicine on a scale from 1 to 5 (1=lowest; 5=highest satisfaction).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: October 31, 2020
• Est. primary completion date: August 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients contacted by telemedicine (phone and/or video call) during the COVID-19 pandemic in outpatient clinics

• Follow-up of patients with any chronic disease and postoperative patients, preoperative and urgent consultation

• Age greater than or equal to 18 years

Exclusion Criteria:

• Patients with cognitive or sensory difficulties or with insufficient comprehension of the language in which the survey is conducted

• Patients who decline to take part in the telephone survey

Related Conditions & MeSH terms

• Covid-19

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptance of telemedicine	Acceptance of telemedicine in consultations during the COVID-19 pandemic. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ) as a model. The resulting questionnaire has 10 questions.	1 month
Secondary	Patient satisfaction	Global satisfaction score on a scale from1 to 5 (1=lowest; 5=highest satisfaction)	1 month